key: cord-0717210-92udc02l
authors: Bostan, Ecem; Gulseren, Duygu; Gokoz, Ozay
title: New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine
date: 2021-07-09
journal: Int J Dermatol
DOI: 10.1111/ijd.15777
sha: 9bdc637e865194752320f483b3c3b7eb0276cd60
doc_id: 717210
cord_uid: 92udc02l

nan

We read the letter by Cohen et al. 1 An otherwise healthy 33-year-old man was seen in our Dermatology Outpatient Clinic due to the emergence of widespread violaceous eruption which started three days after the first dose of inactivated COVID-19 vaccine application. Three months ago, he had mildly symptomatic COVID-19 for which he was treated with oral favipiravir for five days. He reported to have no recent history of infection, fever, cough, arthralgia, or dyspnea. Dermatologic examination revealed erythematous macules and palpable papules on the legs, forearms, and right belly (Fig. 1a-c) . At that time, two punch biopsies were taken from the right forearm for histopathological examination and direct immunofluorescence (DIF) analysis with a pre-diagnosis of LCV. Histopathological examination showed hyperkeratosis in the epidermis, perivascular mixed inflammation, and erythrocyte extravasation in the dermis (Fig. 2a) . DIF analysis revealed IgA deposition within small vessel walls (Fig. 2b) . Five days later, his cutaneous lesions had turned into vivid purpuric palpable papules (Fig. 1d-e) . He did not have any known rheumatologic or dermatologic disorder; complete blood count, liver/kidney function tests, urinalysis, chest x-ray, and stool guaiac test were all within normal limits. Rheumatologic markers were negative. He was diagnosed with IgA vasculitis without systemic involvement by clinicopathological correlation.

Topical mometasone furoate was prescribed twice daily with partial resolution. 

Leukocytoclastic vasculitis flare following the COVID-19 vaccine

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Histopathologic approach to cutaneous vasculitis

Vasculitis as an adverse event following immunization -Systematic literature review

Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination